| NAME |
ALBIGLUTIDE 50MG/0.5ML INJ,SOLN,PEN,0.5ML |
| VA GENERIC NAME |
ALBIGLUTIDE |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Albiglutide_(Tanzeum)_(2017).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
50 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2019-07-15 00:00:00 |
| UNITS |
MG/0.5ML |
| NATIONAL FORMULARY NAME |
ALBIGLUTIDE INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
ALBIGLUTIDE 50MG/0.5ML INJ PEN 0.5ML |
| VA PRODUCT IDENTIFIER |
A1757 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
EA |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4033419 |
| EFFECTIVE DATE/TIME |
-
- 2014-06-19 00:00:00
- STATUS: ACTIVE
-
- 2019-07-15 00:00:00
- STATUS: INACTIVE
-
- 2019-07-15 00:00:00
- STATUS: INACTIVE
|